CClinicalTrials.gg
WithdrawnNCT04794816Updated Oct 14, 2025

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care

An observational study in Breast Carcinoma, sponsored by M.D. Anderson Cancer Center. Withdrawn. Open to female participants aged 30 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-14.

Sponsored by M.D. Anderson Cancer Center · Observational

Why this study was withdrawn
0 participants
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
0
Ages
30 Years and older
Sex
Female
01

Study summary

This study explores why patients may want to receive real-time imaging results during a screening mammogram appointment at an MD Anderson breast imaging center. Real-time imaging results means women receive the results of the mammogram right away during the same clinic visit. Information from this study may help researchers better understand patient preferences to enhance patient-experience driven care.

Read the detailed description

PRIMARY OBJECTIVE:

I. To identify factors that may influence a patient's desire to receive real-time imaging results during their screening mammogram appointment at a breast center.

OUTLINE:

Participants complete an online questionnaire over 5 minutes regarding information on patient demographics and preferences for receiving real-time appointment imaging results.

02

Conditions studied

  • Breast Carcinoma

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

Browse Breast Neoplasms studies →

Lead sponsor

M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 579 are open to participants now.

Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who are scheduled for a screening mammogram at one of three MD Anderson Breast Imaging Houston Area Locations (League City, Diagnostic Imaging (DI)-West Houston and The Woodlands) between December 15, 2020 and March 31, 2022.

Inclusion criteria

  • All female patients scheduled for a screening mammogram at one of our three MD Anderson Cancer Center (MDACC) Breast Imaging Houston Area Location centers
  • Patient >= 30 years of age
  • Able to complete an electronic informed consent for the study

Exclusion criteria

Exclusion Criteria:

  • Patients not scheduled for a screening mammogram at one of the three imaging facilities
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Observational (questionnaire administration)

    Participants complete an online questionnaire over 5 minutes regarding information on patient demographics and preferences for receiving real-time appointment imaging results.

    Other: Questionnaire Administration

Interventions

  • OtherQuestionnaire Administration

    Complete questionnaire

06

What researchers measure

Primary outcomes

  1. Factors that may influence a patient's desire to receive real-time imaging results during their screening mammogram appointment at a breast center

    Descriptive analyses will include the characterization of patients and preferences by age, location, patient education level, ethnicity, and patient cancer history.

    Time frame: Up to study completion (estimated 2 years)

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Informed consent form · Nov 9, 2020

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04794816
Lead sponsor
M.D. Anderson Cancer Center
Responsible party
Sponsor
First posted
Mar 12, 2021
Start date
Jan 21, 2021
Primary completion
Oct 6, 2025
Completion
Oct 6, 2025
Last update
Oct 14, 2025

Study contacts

Megan J Kalambo, MD
principal investigator · M.D. Anderson Cancer Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion